eScholarship
metadata only
Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy
BACKGROUND: Elevated CSF τ is considered a biomarker of neuronal injury in newly developed Alzheimer's disease (AD) and mild cognitive impairment (MCI) criteria. However, previous studies have failed to detect alterations of τ species in other primary tauopathies. We assessed CSF τ protein abnormali
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy#1203926
- Age‐Dependent Regulation of Hippocampal Inflammation by the Mitochondrial Translocator Protein in Mice#1203930
- SRSF1 as a promising biomarker and key player in the pathogenesis of Alzheimer's disease.#143117
- Staging of amyloid β, t‐tau, regional atrophy rates, and cognitive change in a nondemented cohort: Results of serial mediation analyses#1263577
- Bayesian modelling demonstrates clinically relevant heterogeneity in Tau PET patterns in Alzheimer’s disease#219897
Record · ID 1366470
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive